C&D Emerging Industry Equity Investment
Xiamencndexin.com
Overview
C&D Emerging Industry Equity Investment is a professional equity asset management institution under C&D Group, focusing on emerging industries in China, including the medical and health, advanced manufacturing, and TMT/consumption sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Boundary.AI | Apr 2026 | Series B | Lead |
| ShengShu Technology | Feb 2026 | Series A Extension | Co-investor |
| Phrontline Biopharma | Nov 2025 | pre_series_a_plus | Co-investor |
| Kind Pharmaceutical | Nov 2025 | Series C | Lead |
| 九识（苏州）智能科技有限公司 | Apr 2025 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
